Nov 19, 2019 / 06:50PM GMT
Daniel Anthony Arias - Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst
Okay. Our next section -- session is going to be with Bio-Techne. We're happy to have Chuck Kummeth, the CEO here. I think we'll do a similar thing and that he'll spend a couple of minutes on some slides, and then we'll just go into Q&A right afterwards. Chuck, Thanks.
Charles R. Kummeth - Bio-Techne Corporation - CEO, President & Director
Thank you. Well, presentation, but probably too long for a chat. We're going to go really fast on these. So they're actually online too if you want this short deck. We loaded it today, I think, right? Okay. I should mention that we do have a -- this our new tagline, Dan, so where science intersects innovation.
So innovation pretty overused. Combined with science, maybe better, we'll see, but anyway after waiting a year and saying no to marketing 349 times, I had to give in on one. So this is us and headquarters, still Minneapolis, too many locations for our size. We're not really focused on cost
Bio-Techne Corp at Stifel Healthcare Conference Transcript
Nov 20, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers